BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 2 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 2 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 2 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 2 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 2 days ago Abbott reports positive results from study on its atrial fibrillation therapies 2 days ago Atmus Welcomes Heath Sharp to Board of Directors 2 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 2 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 4 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 4 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 2 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 2 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 2 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 2 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 2 days ago Abbott reports positive results from study on its atrial fibrillation therapies 2 days ago Atmus Welcomes Heath Sharp to Board of Directors 2 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 2 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 4 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 4 days ago
ADVERTISEMENT
Market News

Veeva Systems (VEEV) Q4 results exceed estimates; stock gains

Veeva Systems Inc. (NYSE: VEEV) , a provider of cloud-based solutions to the healthcare industry, reported stronger-than-expected earnings and revenues for the fourth quarter of 2020. The company’s stock gained during Tuesday’s after-hours session, immediately after the announcement. Related: Veeva Q3 2020 Earnings Conference Call Transcript Fourth-quarter revenues climbed 34% annually to $311.5 million and far […]

$VEEV March 3, 2020 2 min read

Veeva Systems Inc. (NYSE: VEEV) , a provider of cloud-based solutions to the healthcare industry, reported stronger-than-expected earnings and revenues for the fourth quarter of 2020. The company’s stock gained during Tuesday’s after-hours session, immediately after the announcement.

Related: Veeva Q3 2020 Earnings Conference Call Transcript

Fourth-quarter revenues climbed 34% annually to $311.5 million and far exceeded the estimates, supported by strong subscription growth.

Earnings up 20%

Earnings, adjusted for one-off items, moved up to $0.54 per share from $0.45 per share in the comparable period of last year. The bottom-line also topped Wall Street’s projection. Net income was $66.2 million or $0.42 per share, compared to $71.2 million or $0.45 per share a year earlier.

Veeva Systems Financial Summary

“The past year was an exceptional one for Veeva. We focused on customer success and accelerated our pace of innovation in established and new markets. Our leadership is fueled by a track record of identifying and bringing great cloud solutions to large, underserved markets and a relentless focus on customer success,” said CFO Tim Cabral.

ADVERTISEMENT

Outlook

Encouraged by the impressive outcome, the management currently expects an increase in first-quarter adjusted earnings to $0.59-$0.60 per share. Revenues are estimated to be in the range of $327 million to $328 million. For the first three months of fiscal 2021, the company is looking for adjusted operating income of $117-$118 million.

For the whole of fiscal 2021, Veeva expects adjusted earnings to be around $2.50 per share. The estimate of full-year revenue is in the range of $1.400 billion to $1.405 billion, while adjusted operating income is expected to be approximately $500 million.

Strength

Veeva has a unique portfolio that caters to the various technology-related requirements of the pharmaceutical and life sciences industries. The company has constantly revamped its product line and expanded the business to new markets.

Also read: Acuity Brands Stock: Tariff, demand woes call for caution

Veeva’s stock has gained 24% in the past twelve months and is currently trading at the levels seen at the beginning of the year. The shares closed Tuesday’s regular session lower but gained sharply during the extended trading hours.

ADVERTISEMENT

Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text.

ADVERTISEMENT